The research & development by business enterprise, pharmaceutical industry in local currency in Iceland is currently 16.20 million, a decrease of 6.73 million (-29.3%) compared to 2021.
Research & development by business enterprise, pharmaceutical industry in local currency in Iceland
No matching regions
Similar regions to Iceland
Business R&D pharmaceutical in local currency
More indicators for Iceland
Government R&D in security as % of government support
0%
0%
(2021)
Higher-education-finacing R&D financed by general university in local currency
61,479.53M
+8,624.32M
(2022)
R&D financed by rest of the world in local currency
178,428.87M
-17,726.91M
(2022)
Government R&D financed by rest of the world in local currency
2,060.04M
+1,392.46M
(2022)
Business R&D financed by rest of the world in local currency
154,963.49M
-25,404.12M
(2022)
Non-profit R&D growth rate
-3.2%
-2.63%
(2009)
Iceland Business R&D pharmaceutical in local currency between 2013 and 2022
| Period | Business R&D pharmaceutical in local currency | Change |
|---|---|---|
| 2022 | 16.20M | -6.73M |
| 2021 | 22.93M | -35.07M |
| 2020 | 58.00M | +10.80M |
| 2019 | 47.20M | -152.80M |
| 2018 | 200.00M | +50.00M |
| 2017 | 150.00M | -44.80M |
| 2016 | 194.80M | +54.20M |
| 2015 | 140.60M | +107.50M |
| 2014 | 33.10M | -15.20M |
| 2013 | 48.30M |